| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 对乙酰胺基酚可直压颗粒(元) | 114,402,014.35 | 306,640,842.52 | 178,953,413.87 | 360,460,172.85 | 136,753,091.31 |
| 对乙酰胺基酚原料药(元) | 89,706,582.27 | 311,209,474.80 | 208,708,338.50 | 308,106,106.81 | 122,341,476.47 |
| 其他制剂(元) | 3,841,208.97 | 10,611,138.28 | 6,826,777.41 | 11,037,186.33 | 4,158,798.35 |
| 其他原料药(元) | 7,503,303.17 | 20,013,777.70 | 9,420,042.35 | 15,126,764.39 | 7,324,154.86 |
| 营业成本(元) | |||||
| 对乙酰胺基酚可直压颗粒(元) | 66,336,628.37 | 193,662,354.92 | 117,301,572.07 | 234,779,510.88 | 91,076,970.47 |
| 对乙酰胺基酚原料药(元) | 48,351,546.12 | 180,034,903.09 | 124,183,473.03 | 210,965,446.27 | 85,490,678.03 |
| 其他制剂(元) | 2,612,934.83 | 5,613,314.04 | 2,820,319.36 | 6,411,386.72 | 2,820,092.53 |
| 其他原料药(元) | 4,041,505.72 | 8,331,869.68 | 3,305,861.42 | 8,736,235.29 | 4,840,557.66 |
| 毛利(元) | |||||
| 对乙酰胺基酚可直压颗粒(元) | 48,065,385.98 | 112,978,487.60 | 61,651,841.80 | 125,680,661.97 | 45,676,120.84 |
| 对乙酰胺基酚原料药(元) | 41,355,036.15 | 131,174,571.71 | 84,524,865.47 | 97,140,660.54 | 36,850,798.44 |
| 其他制剂(元) | 1,228,274.14 | 4,997,824.24 | 4,006,458.05 | 4,625,799.61 | 1,338,705.82 |
| 其他原料药(元) | 3,461,797.45 | 11,681,908.02 | 6,114,180.93 | 6,390,529.10 | 2,483,597.20 |
| 毛利率(%) | |||||
| 对乙酰胺基酚可直压颗粒(%) | 42.01 | 36.84 | 34.45 | 34.87 | 33.40 |
| 对乙酰胺基酚原料药(%) | 46.10 | 42.15 | 40.50 | 31.53 | 30.12 |
| 其他制剂(%) | 31.98 | 47.10 | 58.69 | 41.91 | 32.19 |
| 其他原料药(%) | 46.14 | 58.37 | 64.91 | 42.25 | 33.91 |
| 收入构成(%) | |||||
| 对乙酰胺基酚可直压颗粒(%) | 53.10 | 47.29 | 44.31 | 51.88 | 50.54 |
| 对乙酰胺基酚原料药(%) | 41.64 | 47.99 | 51.67 | 44.35 | 45.21 |
| 其他制剂(%) | 1.78 | 1.64 | 1.69 | 1.59 | 1.54 |
| 其他原料药(%) | 3.48 | 3.09 | 2.33 | 2.18 | 2.71 |
| 毛利构成(%) | |||||
| 对乙酰胺基酚可直压颗粒(%) | 51.07 | 43.31 | 39.45 | 53.75 | 52.90 |
| 对乙酰胺基酚原料药(%) | 43.94 | 50.29 | 54.08 | 41.54 | 42.68 |
| 其他制剂(%) | 1.31 | 1.92 | 2.56 | 1.98 | 1.55 |
| 其他原料药(%) | 3.68 | 4.48 | 3.91 | 2.73 | 2.88 |